Emerging BioTalk
  • Home
  • About Us
  • Contact
  • Search
  • Menu

Diagnosing, targeting and treating cancer using a recombinant cancer binding malaria protein – April 23 2021

April 14, 2021/in Webinar /by Ali Salanti M.Sc., PhD

Click HERE To register for a LIVE presentation from industry expert Ali Salanti (PhD) on Diagnosing, targeting and treating cancer using a recombinant cancer binding malaria protein. 

Abstract includes: 

Rapid growth and tissue invasion are features shared by cancer and the placenta. For the placenta this is essential to support fetal growth but in cancer it is detrimental. Malaria parasites have evolved a protein called VAR2CSA that binds a distinct carbohydrate modification present on placental cells.  This placental CSA is not found on normal somatic cells, and VAR2CSA is the only reagent that can distinguish normal CSA from placental CSA. We have shown that placental CSA is present on the large majority of cancer cells, and that these cells effectively binds and internalizes VAR2CSA upon contact. Normal cells and non-malignant tissue does not bind VAR2CSA. This potentially makes VAR2CSA ideal as a broadly effective cancer drug. VAR2 Pharmaceuticals has developed a VAR2CSA Drug Conjugate (VDC) that effectively kills cancer cells in vitro and in vivo with no acute adverse effects. Our focus is to transition this as well as a VAR2CSA protein fused to anti-CD3 to clinical phase I trials. Such novel therapies holds the promise to provide an effective and safe therapeutic options for the many types of cancers with no current targeted therapies available. 

Click here to register. 

  • Author
  • Recent Posts
Ali Salanti M.Sc., PhD
Born in Denmark, August 20, 1974. Married and two children. Lives in Farum at Gammelgårdsvej 18, 3520. Professor at University of Copenhagen
Latest posts by Ali Salanti M.Sc., PhD (see all)
  • Diagnosing, targeting and treating cancer using a recombinant cancer binding malaria protein – April 23 2021 - April 14, 2021

0
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn
  • Share by Mail
http://emergingbiotalk.com/wp-content/uploads/2021/04/symposium_join_us_live.png 650 1200 Ali Salanti M.Sc., PhD http://emergingbiotalk.com/wp-content/uploads/2020/05/emergingbiotalk-header.png Ali Salanti M.Sc., PhD2021-04-14 15:40:432021-04-14 15:41:02Diagnosing, targeting and treating cancer using a recombinant cancer binding malaria protein - April 23 2021

Biotech Resource Hub >>

  • SUBSCRIBE TO OUR BLOG
  • SUBMIT YOUR BLOG POST

Latest News

  • 5 Minutes could win you $275,000 in products and services!January 30, 2023 - 8:50 am
  • Upcoming Seminar in India: Fast track through regulatory challengesFebruary 6, 2023 - 1:10 pm
  • Enter for a chance to win $275,000 in products and services!January 9, 2023 - 11:14 am

Categories

  • Bioprocessing
  • Biosafety Testing
  • End-to-End Solutions
  • Frontpage Article
  • Gene Therapy
  • Investigator's Brochure
  • News
  • Uncategorized
  • Vaccines
  • Viral Vectors
  • Webinar

Archives

  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • May 2020
  • April 2020
  • SUBSCRIBE TO OUR BLOG
  • SUBMIT YOUR BLOG POST

Latest News

  • 5 Minutes could win you $275,000 in products and services!January 30, 2023 - 8:50 am
  • Upcoming Seminar in India: Fast track through regulatory challengesFebruary 6, 2023 - 1:10 pm
  • Enter for a chance to win $275,000 in products and services!January 9, 2023 - 11:14 am

Categories

  • Bioprocessing
  • Biosafety Testing
  • End-to-End Solutions
  • Frontpage Article
  • Gene Therapy
  • Investigator's Brochure
  • News
  • Uncategorized
  • Vaccines
  • Viral Vectors
  • Webinar

Archives

  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • May 2020
  • April 2020

Tags

applications bioprocessing biotech blazar Congratulations Content education Europe FDA Format gene therapy grant grants Investigator's Brochure molecule new NGS Pharmaceuticals program services symposia tags things Tone VAR2 viral assurance viral clearance virus virus detection winner

Business Hours

Our support Hotline is available 24 Hours a day: (555) 343 456 7891

  • Monday-Friday: 9am to 5pm
  • Saturday: 10am to 2pm
  • Sunday: Closed

Latest News

  • 5 Minutes could win you $275,000 in products and services!January 30, 2023 - 8:50 am
  • Upcoming Seminar in India: Fast track through regulatory challengesFebruary 6, 2023 - 1:10 pm
  • Enter for a chance to win $275,000 in products and services!January 9, 2023 - 11:14 am
  • The Future of BiopharmaDecember 6, 2022 - 4:39 am
  • Last chance: 3rd Annual Startup Symposium – Day 3November 10, 2022 - 5:39 am
  • The Lack of Funding for Women Entrepreneurs Doesn’t Stop Them from Launching – But We Still Have a Long Way to Go – And We Can Help Each Other. Assurea is ROOTING FOR YOU!October 21, 2022 - 8:27 am

Categories

  • Bioprocessing
  • Biosafety Testing
  • End-to-End Solutions
  • Frontpage Article
  • Gene Therapy
  • Investigator's Brochure
  • News
  • Uncategorized
  • Vaccines
  • Viral Vectors
  • Webinar
  • Author
  • Recent Posts
Ali Salanti M.Sc., PhD
Born in Denmark, August 20, 1974. Married and two children. Lives in Farum at Gammelgårdsvej 18, 3520. Professor at University of Copenhagen
Latest posts by Ali Salanti M.Sc., PhD (see all)
  • Diagnosing, targeting and treating cancer using a recombinant cancer binding malaria protein – April 23 2021 - April 14, 2021
0
© 2020 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved. | Privacy Policy | Cookie Settings
ImCheck: Exploring two uncharted territories in immunomodulation, butryophilins... A new shared-risk partnership model for developing and commercializing oncology...
Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. We use cookies in our website to give you the most relevant experience. By clicking or navigating the site, you are accepting the use of all our cookies according to our Cookie Policy / Privacy Statement. You are free to decide in the Cookie Settings which categories you would like to allow. Please note that depending on what you select, the full functionality of the website may no longer be available. You may review and change your choices at any time. Further information can be found in our Privacy Policy

Accept All CookiesCookie Settings

Cookie and Privacy Settings



Cookie Preferences

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about how we use and share your data, please follow this link.
Privacy Statement

Necessary

Always Active
These cookies are necessary for the website to operate. Our website cannot function without these cookies and they can only be disabled by changing your browser preferences.

Functional

These cookies enable the provision of advanced functionalities and are used for personalization. The cookies are set in particular in response to your actions and depend on your specific service requests (e.g., pop-up notification choices).Changes will take effect once you reload the page.

Targeting

These cookies may be set to learn more about your interests and show you relevant ads on other websites. These cookies work by uniquely identifying your browser and device. By integrating these cookies, we aim to learn more about your interests and your surfing behavior and to be able to place our advertising in a targeted manner.

Confirm My ChoicesAllow AllDisable All

loading

Please wait while you are redirected to the right page...

Please share your location to continue.

Check our help guide for more info.

share your location